MSDS

Page 4 of 6
2 April 2008
Supercedes 24 June 2003
MSDS No.: MSOL508
VAPOR DENSITY: Not Determined
PERCENT VOLATILE: Not Determined
BOILING POINT: Not Determined
VISCOSITY @ 100 Deg. C 10.0 – 11.5 centistokes
SECTION 10: STABILITY AND REACTIVITY
CHEMICAL STABILITY (CONDITIONS TO AVOID): Material is considered stable at room
temperature and pressure. Avoid heat, sparks and open flame.
INCOMPATIBILITY: Strong oxidizing agents
HAZARDOUS COMBUSTION PRODUCTS: Burning or excessive heating may produce smoke, carbon
monoxide, carbon dioxide, aldehydes and other products of incomplete combustion. Hydrogen
sulfide and alkyl mercaptans and sulfides may also be released. Under combustion conditions the
oxides of calcium, sulfur, phosphorous, zinc and nitrogen will be formed.
POSSIBILITY OF HAZARDOUS REACTIONS: None
SECTION 11: TOXICOLOGICAL INFORMATION
EYE IRRITATION: May cause eye irritation, based on component data.
SKIN IRRITATION: Mild skin irritation may occur upon short-term exposure. Long-term exposure may
cause redness, edema, drying and cracking of skin, based on component data.
RESPIRATORY IRRITATION: No significant adverse health effects are expected to occur under normal
conditions of use. However, exposure to petroleum mist at high levels may be irritating to the nose,
throat and lungs.
ORAL TOXICITY: No significant adverse health effects are expected to occur upon short-term exposure
based on data from components.
CHRONIC TOXICITY: Based on component data, repeated swallowing of a component contained in this
product may cause destruction of the stomach lining. It also caused enlargement of the liver and
thyroid in rat toxicity studies. These effects were reversible upon cessation of treatment.
CARCINOGENICITY: This product is formulated with mineral oils, which are considered to be severely
refined and not considered to be carcinogenic under IARC. The IP346 test has not been used to
evaluate these oils.
MUTAGENICITY: No Data
TERATOLOGY (BIRTH DEFECT) INFORMATION: Based on component data, there are conflicting
reports in the literature regarding the teratogenicity of diphenylamine. However, since the dosage